|
Female sex, N (%)
|
2239 (50.7)
|
92 (42.8)
|
643 (51.8)
|
602 (48.4)
|
902 (52.4)
|
|
Age, years, mean (SD)
|
59.7 (20.8)
|
62.3 (21.5)
|
63.5 (19.2)
|
60.5 (20.7)
|
55.9 (21.3)
|
|
Albumin, (g/L), median (IQR)
|
39 (35–43)
|
36 (32–40)
|
37 (33–40)
|
39 (34–43)
|
41 (38–44)
|
|
CRP (mg/L), median (IQR)
|
4 (3–32)
|
5 (3–33)
|
3 (3–23)
|
5 (3–35)
|
4 (3–41)
|
|
suPAR, ng/mL, median (IQR)
|
3.9 (2.9–5.8)
|
5.6 (3.4–7.1)
|
4.1 (2.9–6.0)
|
3.9 (2.9–5.9)
|
3.8 (2.8–5.4)
|
|
suPAR, patients alive at seven days, ng/mL, median (IQR)
|
3.9 (2.9–5.7)
|
4.8 (3.2–6.5)
|
4.1 (2.9–6.0)
|
3.9 (2.9–5.8)
|
3.8 (2.8–5.4)
|
|
suPAR, patients dead at seven days, ng/mL, median (IQR)
|
8.6 (6.0–12.8)
|
7.9 (5.9–9.7)
|
10.9 (8.1–15.0)
|
7.9 (6.3–11.1)
|
9.8 (5.3–14.7)
|
|
Cancer, N (%)
|
166 (3.8)
|
9 (4.2)
|
41 (3.3)
|
46 (3.7)
|
70 (4.1)
|
|
Cardiovascular disease, N (%)
|
956 (21.6)
|
79 (36.7)
|
419 (33.8)
|
239 (19,2)
|
219 (12.7)
|
|
Infectious disease, N (%)
|
830 (18.8)
|
50 (23.3)
|
207 (16.7)
|
228 (18.3)
|
345 (20.0)
|
|
Neurological disease, N (%)
|
341 (7.7)
|
27 (12.6)
|
117 (2.6)
|
99 (8.0)
|
98 (5.7)
|
|
General surgery, N (%)
|
168 (3.8)
|
6 (2.8)
|
26 (2.1)
|
54 (4.3)
|
82 (4.8)
|
|
Orthopaedic surgery, N (%)
|
154 (3.5)
|
1 (0.5)
|
102 (8.2)
|
26 (2.1)
|
25 (1.5)
|
|
Other, N (%)
|
1805 (40.8)
|
43 (20.0)
|
329 (26.5)
|
551 (44.3)
|
882 (51.2)
|
|
Herlev Hospital, N (%)
|
2780 (62.9)
|
85 (3.1)
|
628 (22.6)
|
683 (24.6)
|
1384 (49.8)
|
|
Bispebjerg Hospital, N (%)
|
1640 (37.1)
|
130 (8.0)
|
613 (37.3)
|
560 (34.2)
|
337 (20.5)
|
|
Hospital admission, N (%)
|
2108 (47.7)
|
143 (66.5)
|
706 (56.9)
|
615 (49.5)
|
644 (37.4)
|
|
Length of stay (days), mean (SD)
|
4.2 (7.1)
|
7.0 (11.1)
|
5.1 (7.9)
|
4.1 (6.2)
|
3.3 (6.2)
|
|
Surgery during admission, N (%)
|
444 (10.0)
|
15 (7.0)
|
164 (13.2)
|
112 (9.0)
|
153 (8.9)
|
|
Readmissions at seven days, N (%)
|
238 (5.4)
|
10 (4.7)
|
72 (5.8)
|
72 (5.8)
|
84 (4.9)
|
|
Mortality at seven days, N (%)
|
58 (1.3)
|
17 (7.9)
|
20 (1.6)
|
12 (1.0)
|
9 (0.5)
|
